RPCA
TECX

Running Point Capital Advisors’s Tectonic Therapeutic TECX Stock Holding History

Running Point Capital Advisors’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-833
Closed -$6K – 233
2022
Q3 		$6K Hold
833
– – ﹤0.01% 204
2022
Q2 		$9K Hold
833
– – 0.01% 204
2022
Q1 		$13K Buy
+833
New +$17.2K 0.01% 198

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Running Point Capital Advisors's TECX Position: Q4 2022 in Review

Running Point Capital Advisors sold out of Tectonic Therapeutic (TECX) in Q4 2022, closing a stake of 833 shares — an estimated $6K sold.

Running Point Capital Advisors first reported a position in TECX in Q1 2022 and held it in 3 quarters. The position peaked at $13K in Q1 2022. 45 funds tracked by Wall St. Rank hold TECX as of Q4 2022.

  • Running Point Capital Advisors reported no remaining Tectonic Therapeutic position as of Q4 2022 after selling out during the quarter.
  • Running Point Capital Advisors sold 833 Tectonic Therapeutic shares in Q4 2022, an estimated $6K.
  • Running Point Capital Advisors first reported a position in Tectonic Therapeutic in Q1 2022 and held it in 3 quarters.
  • Running Point Capital Advisors's Tectonic Therapeutic position peaked at $13K in Q1 2022.
  • 45 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2022.

Based on Running Point Capital Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.